Leukemia
A phase III multi-center, open-label, randomized study of imatinib versus nilotinib in adult patients with newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia in chronic phase (CML-CP) EXTENSION ONLY
Trial ID: 06189
Contact: Marina Torres
Phone: (281)863-4632
Learn More about this trial.
go back | new search